CARLSBAD, Calif., Nov. 30, 2020 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) today announced that the biopharmaceutical company AstraZeneca has initiated a Phase 2b clinical trial of ION449 (AZD8233), an investigational antisense medicine designed to reduce blood cholesterol levels in patients with dyslipidemia by targeting proprotein convertase subtilisin/kexin type 9 (PCSK9), an important regulator […]

Novocure (NASDAQ: NVCR) today announced it has entered into a strategic alliance with the NYU Grossman School of Medicine’s Department of Radiation Oncology that provides a framework for preclinical and clinical development projects studying Tumor Treating Fields. Novocure’s Tumor Treating Fields are electric fields that disrupt cancer cell division. “It […]

CITIID has been repurposed to throw all of its weight behind the fight against COVID-19. It brings to bear upon this global problem over 150 scientists and physicians, the UK’s largest academic containment Level 3 facility, and a range of collaborators from across the UK and beyond. Most importantly, it […]

The information contained in this site provides quality, up-to-date health information as a resource for both medical practitioners and the wider community. Paediatric Improvement Collaborative (PIC) RCH has partnered with the NSW Agency for Clinical Innovation, Queensland Health Clinical Excellence Division and Safer Care Victoria to form the Paediatric Improvement […]